Research Dashboard (Demo)
Mock data showing aggregate insights • Updated: June 2024
Total Dataset
50,234
Sessions
🔒
Demo Dashboard
This is a demonstration with mock data. Real institutional access provides:
- ✓ Live data updates (quarterly)
- ✓ Custom query builder with 50+ filters
- ✓ CSV/API export capabilities
- ✓ Statistical significance testing
- ✓ Demographic breakdowns by state, age, gender, conditions
Total Users
10,234
↑ 23% vs last quarter
Sessions Logged
50,234
↑ 31% vs last quarter
Vitals Readings
25,118
↑ 45% vs last quarter
Unique Strains
523
↑ 12% vs last quarter
Dataset Growth Over Time
❤️ Cardiovascular Impact Analysis
Heart Rate Change by Top Strains
Key Finding: Myrcene-dominant strains show consistent HR reduction of 8-12 BPM (p < 0.01, n = 1,052)
Blood Pressure by Dominant Terpene
Key Finding: Myrcene + Linalool combination reduces systolic BP by avg 7.6 mmHg in hypertensive patients (p < 0.001)
THC Percentage vs Heart Rate Change (Correlation: r = -0.73)
Key Finding: Strong negative correlation between THC percentage and HR reduction. Optimal range: 20-25% THC for cardiovascular benefits.
👥 User Demographics
Age Distribution
Top Health Conditions (Self-Reported)
😊 Wellness Improvements by Condition
Anxiety
42.3%
avg improvement (n = 4,520)
Insomnia
38.7%
avg improvement (n = 3,210)
Chronic Pain
31.5%
avg improvement (n = 2,890)
Hypertension
28.9%
avg improvement (n = 1,650)
Depression
35.2%
avg improvement (n = 1,420)
PTSD
45.8%
avg improvement (n = 890)
🔬 Research-Grade Insights
Cardiovascular Effects
- • 68% of sessions show HR decrease (avg -7.8 BPM)
- • Myrcene-dominant strains: -8.2 systolic, -4.1 diastolic
- • Strong correlation: THC 20-25% = optimal CV benefits
- • No adverse effects in patients on antihypertensives
Mental Health Outcomes
- • Anxiety: 42% average symptom reduction
- • Depression: 35% improvement in mood scores
- • PTSD: 46% reduction in intrusive symptoms
- • Sleep quality: 39% improvement reported